Immune gene expression signatures associated clinical benefit from nivolumab and ipilimumab for previously treated patients with stage IV squamous cell lung cancer: An immune biomarker analysis of phase III SWOG LungMAP S1400I trial

被引：0

作者：

Duose, Dzifa Y. ^{[1
]}

Zhang, Jiexin ^{[1
]}

Redman, Mary ^{[2
]}

Zhang, Baili ^{[1
]}

Cerami, Ethan ^{[3
]}

Lindsay, James ^{[3
]}

Yu, Joyce ^{[3
]}

Biswas, Roshni ^{[3
]}

Van Nostrand, Stephen ^{[3
]}

Moravec, Radim ^{[4
]}

Luthra, Rajyalakshmi ^{[1
]}

Al-Atrash, Gheath ^{[1
]}

Kelly, Karen ^{[5
]}

Herbst, Roy ^{[6
]}

Wistuba, Ignacio ^{[1
]}

Gettinger, Scott ^{[6
]}

Bazhenova, Lyudmila ^{[7
]}

Lee, J. Jack ^{[1
]}

Zhang, Jianjun ^{[1
]}

Haymaker, Cara ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[2] Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[3] Dana Farber Canc Inst, Boston, MA USA

[4] Natl Canc Inst, Bethesda, MD USA

[5] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA USA

[6] Yale Sch Med, New Haven, CT USA

[7] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1974

引用

页数：2

共 24 条

[21] Top-line results from SUNRISE: A phase III, randomized, double-blind, placebo-controlled multicenter trial of bavituximab plus docetaxel in patients with previously treated stage IIIb/iv non-squamous non-small cell lung cancer
Spigel, D. R.
Bondarenko, I.
Losonczy, G.
Mezger, J.
Kalofonos, H.
Reck, M.
Palmero, R.
Jang, T.
Natale, R.
Sanborn, R. E.
Lai, J.
Kallinteris, N.
Tang, M.
Shan, J.
Gerber, D.
ANNALS OF ONCOLOGY, 2016, 27
[22] NeoRad(Low): A phase 2 trial of neoadjuvant (NA) ipilimumab plus nivolumab (ipi plus nivo) with low dose stereotactic body radiation therapy (SBRT) as an immune stimulant in patients with resectable stage IB-III non-small cell lung cancer (NSCLC)
DiPetrillo, Thomas A.
Garcia-Moliner, Maria
Koffer, Paul
Hepel, Jaroslaw T.
Khan, Hina
Khurshid, Humera
Abbas, Abbas
Birnbaum, Ariel E.
Olszewski, Adam J.
Ferreira, Cheyenne
Hassinger, Faith
McCormick, Michele Carlin
Giesing, Hannah
Rodrigues, Nuno
Rosati, Vallerie
Wood, Roxanne
Webber, Amy
Maleki, Sara
Azzoli, Christopher G.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[23] Elderly patients benefit from second-line cytotoxic chemotherapy: A subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer (vol 24, pg 4405, 2006)
Weiss
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) : 5477 - 5477
[24] EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC
Hirsch, Fred R.
Redman, Mary W.
Moon, James
Agustoni, Francesco
Herbst, Roy S.
Semrad, Thomas J.
Varella-Garcia, Marileila
Rivard, Chris J.
Kelly, Karen
Gandara, David R.
Mack, Philip C.
CLINICAL LUNG CANCER, 2022, 23 (01) : 60 - 71

← 1 2 3 →